State Lawmakers Likely To Deal Questions About Oral Phenylephrine Into 2024 Legislation Deck

State government authority is limited to make changes concerning OTC sales, including oral products with phenylephrine. “As we've learned in the past, that hasn't stopped them before. We're going to be monitoring this very closely going into next year,” says CHPA state legislature lobby chief Carlos Gutierrez.

• Source: Shutterstock

State lawmakers could add a card to the frequently shuffled deck of legislation the consumer health products industry will manage in 2024 by considering limiting access to OTC oral phenylephrine nasal decongestants due to doubts about the ingredient’s efficacy.

More from Legislation

More from Policy & Regulation